Koyfin Home > Directory > Health Care > Arena Pharmaceutical > Capital Expenditures

Arena Pharmaceutical Capital Expenditures Chart (ARNA)

Arena Pharmaceutical annual/quarterly Capital Expenditures from 2000 to 2018.
  • Arena Pharmaceutical Capital Expenditures for the quarter ending September 09, 2018 was $0m a 97.50% decrease of 0m year over year
  • Arena Pharmaceutical Capital Expenditures for the last 12 months ending September 09, 2018 was $-1m a 214.02% decrease of -1m year over year
  • Arena Pharmaceutical Annual Capital Expenditures for 2008 was $-20m a 77.44% decrease of -15m from 2007
  • Arena Pharmaceutical Annual Capital Expenditures for 2004 was $-4m a -291.53% increase of 13m from 2003
  • Arena Pharmaceutical Annual Capital Expenditures for 2003 was $-17m a -40.72% increase of 7m from 2002
Other Cash Flow Metrics:
  • Arena Pharmaceutical Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceutical Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceutical Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Capital Expenditures Data

09/2018$0m
06/2018$0m
03/2018$0m
09/2017$0m
06/2017$0m
03/2017$0m
09/2016$0m
06/2016$0m
03/2016$0m
12/2015$11m

Annual ARNA Capital Expenditures Data

2008$-20m
2004$-4m
2003$-17m
2002$-24m
2001$-21m
2000$-2m
1999$-2m